12/3 Webinar: Introducing Tandem Mobi Tubeless. Register Here

Introducing Tandem Mobi Tubeless

Nov 13, 2026

Tandem Mobi Tubeless is now FDA cleared! If you are a healthcare professional interested in learning more, join our upcoming webinar, “Introducing Tandem Mobi Tubeless."

  • Get a closer look at this exciting update from Tandem Diabetes Care

  • Explore key features of Tandem Mobi Tubeless and what they could mean for patients

  • Dive into real-world patient cases highlighting how Tandem Mobi and Control-IQ+ technology can meet a wide range of patient needs today and into the future

Register today:

December 3, 2026 | 12:15 PM ET - Register for Webinar

December 3, 2026 | 12:15 PM CT - Register for Webinar

December 3, 2026 | 12:15 PM MT - Register for Webinar

December 3, 2026 | 12:15 PM PT - Register for Webinar


Important Safety Information

RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older.

Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely.

Safety info: tandemdiabetes.com/safetyinfo